Julie Smith
CIK 1557928 · President and CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.53M
Companies
4
Total Filings
39
Lifetime Open-Market Net
-$8.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STOK | Director | — | $32.23 | — | $0 | 7 | 2026-06-05 |
| EXEL | Director | 28,957 | $52.96 | $1.53M | -$8.07M | 16 | 2026-05-29 |
| BOLD | Director | — | $2.82 | — | $0 | 5 | 2020-01-15 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | President and CEO | 64,179 | — | — | $0 | 7 | 2016-10-26 |
Recent Filings · Page 2 of 4
39 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-07 | STOK | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | EXEL | Grant (A) | +10,015 | $0 | EDGAR |
| 2024-05-23 | EXEL | Sell (S) | −27,280 | -$576.2K | EDGAR |
| 2024-05-21 | EXEL | Notice (144) | −27,280 | -$576.1K | EDGAR |
| 2023-06-15 | STOK | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | EXEL | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | STOK | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | EXEL | Grant (A) | — | $0 | EDGAR |
| 2021-06-25 | STOK | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | EXEL | Grant (A) | +16,424 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.